SM
Therapeutic Areas
Tenon Medical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Catamaran SI Joint Fusion System | Sacroiliac joint fusion for disruptions and degenerative sacroiliitis | Post-Market |
| MAINSAIL Post-Market Study | Safety & Efficacy of Catamaran System for SI Joint Fusion | Post-Market Clinical Follow-up |
Leadership Team at Tenon Medical
SF
Steven Foster
Chief Executive Officer, President & Chairman
RF
Richard Ferrari
Executive Chairman, Founder & Director
RG
Richard Ginn
Chief Technology Officer, COO, Founder & Director
KW
Kevin Williamson
Chief Financial Officer
NG
Nate Grawey
Chief Commercial Officer
WG
Wyatt Giest
Chief Innovation Officer
SH
Stephen H. Hochschuler
Board Director
IH
Ivan Howard
Board Director
RK
Robert K. Weigle
Board Director
KJ
Kristine Jacques
Board Director